Literature DB >> 1934238

[Control of onchocerciasis with ivermectin: results of a mass campaign in northern Cameroon].

J Prod'hon1, M Boussinesq, G Fobi, J M Prud'hom, P Enyong, C Lafleur, D Quillévéré.   

Abstract

A mass chemotherapy campaign to treat onchocerciasis with ivermectin was carried out in northern Cameroon, in the North Vina valley, a savanna area that is part of the extended Vina-Pendé-Longone focus. More than 20,000 people aged five years and over were treated at least once and more than 30,000 treatments were distributed. One to four treatments were given at intervals of six months or one year. Clinical and parasitological examinations of representative samples of the treated population and full ophthalmological examinations of males aged 15 to 35 years were carried out before each treatment to assess the efficacy of the different protocols of treatment. Secondary effects were recorded daily during the week after administration of ivermectin in the whole population treated. The evolution of arterial blood pressure was monitored over seven days in about 300 adults living in the hyperendemic region. The impact of mass treatment on natural transmission of the disease was evaluated by daily capture and dissection of blackflies during the month before and the two months after treatment. All levels of onchocerciasis endemicity were represented in the study area (maximum community microfilarial load (CMFL), 300 microfilariae per biopsy). Six months and one year after the first treatment, loads were down by more than 90% and more than 60% respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1934238      PMCID: PMC2393233     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  8 in total

1.  Community-based treatment with ivermectin.

Authors:  J A Whitworth; D Morgan; G H Maude; D W Taylor
Journal:  Lancet       Date:  1988-07-09       Impact factor: 79.321

2.  [An attempt to normalize the methodology of clinico parasitologic surveys of onchocerciasis in West-Africa (author's transl)].

Authors:  J P Moreau; A Prost; J Prod'hon
Journal:  Med Trop (Mars)       Date:  1978 Jan-Feb

3.  [Parasitological diagnosis of onchocerciasis. A critical review of present methods (author's transl)].

Authors:  A Prost; J Prod'hon
Journal:  Med Trop (Mars)       Date:  1978 Sep-Oct

Review 4.  The status of ivermectin in the treatment of human onchocerciasis.

Authors:  H R Taylor; B M Greene
Journal:  Am J Trop Med Hyg       Date:  1989-10       Impact factor: 2.345

5.  Ocular onchocerciasis and intensity of infection in the community. I. West African savanna.

Authors:  J Remme; K Y Dadzie; A Rolland; B Thylefors
Journal:  Trop Med Parasitol       Date:  1989-09

6.  [A study in the Ivory Coast (1985-1987) of the efficacy and tolerance of ivermectin (Mectizan) in human onchocerciasis. I. A comparative double-blind study of 220 patients with onchocerciasis treated with a single oral dose of 100, 150 or 200 mcg/kg].

Authors:  M Larivière; B Beauvais; M Aziz; J F Garin; J Abeloos; F Derouin; M Bamba; C Bossebceuf; M Ferly-Therizol; C Sarfati
Journal:  Bull Soc Pathol Exot Filiales       Date:  1989-01

7.  Ocular findings in a double-blind study of ivermectin versus diethylcarbamazine versus placebo in the treatment of onchocerciasis.

Authors:  K Y Dadzie; A C Bird; K Awadzi; H Schulz-Key; H M Gilles; M A Aziz
Journal:  Br J Ophthalmol       Date:  1987-02       Impact factor: 4.638

8.  A force-of-infection model for onchocerciasis and its applications in the epidemiological evaluation of the Onchocerciasis Control Programme in the Volta River basin area.

Authors:  J Remme; O Ba; K Y Dadzie; M Karam
Journal:  Bull World Health Organ       Date:  1986       Impact factor: 9.408

  8 in total
  5 in total

1.  Impact of combined large-scale ivermectin distribution and vector control on transmission of Onchocerca volvulus in the Niger basin, Guinea.

Authors:  P Guillet; A Sékétéli; E S Alley; H Agoua; B A Boatin; Y Bissan; L K Akpoboua; D Quillévéré; E M Samba
Journal:  Bull World Health Organ       Date:  1995       Impact factor: 9.408

2.  First evidence of lymphatic filariasis transmission interruption in Cameroon: Progress towards elimination.

Authors:  Hugues C Nana-Djeunga; Magellan Tchouakui; Guy R Njitchouang; Jules B Tchatchueng-Mbougua; Philippe Nwane; André Domche; Jean Bopda; Stève Mbickmen-Tchana; Julie Akame; Ann Tarini; Emilienne Epée; Benjamin D Biholong; Yaobi Zhang; Jean J Tougoue; Achille Kabore; Flobert Njiokou; Joseph Kamgno
Journal:  PLoS Negl Trop Dis       Date:  2017-06-29

3.  The impact of ivermectin on onchocerciasis in villages co-endemic for lymphatic filariasis in an area of onchocerciasis recrudescence in Burkina Faso.

Authors:  Achille S Nikièma; Lassane Koala; Apoline K Sondo; Rory J Post; Alain B Paré; Claude M Kafando; Roger S Kambiré; Bazoumana Sow; Clarisse Bougouma; Roch K Dabiré; Soungalo Traoré
Journal:  PLoS Negl Trop Dis       Date:  2021-03-01

4.  A randomized, single-ascending-dose, ivermectin-controlled, double-blind study of moxidectin in Onchocerca volvulus infection.

Authors:  Kwablah Awadzi; Nicholas O Opoku; Simon K Attah; Janis Lazdins-Helds; Annette C Kuesel
Journal:  PLoS Negl Trop Dis       Date:  2014-06-26

5.  A Test-and-Not-Treat Strategy for Onchocerciasis in Loa loa-Endemic Areas.

Authors:  Joseph Kamgno; Sébastien D Pion; Cédric B Chesnais; Matthew H Bakalar; Michael V D'Ambrosio; Charles D Mackenzie; Hugues C Nana-Djeunga; Raceline Gounoue-Kamkumo; Guy-Roger Njitchouang; Philippe Nwane; Jules B Tchatchueng-Mbouga; Samuel Wanji; Wilma A Stolk; Daniel A Fletcher; Amy D Klion; Thomas B Nutman; Michel Boussinesq
Journal:  N Engl J Med       Date:  2017-11-08       Impact factor: 91.245

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.